Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Boehringer Ingelheim and Inventiva, a French biopharmaceutical company specializing in the development of innovative therapies for fibrosis, oncology and orphan diseases, have announced a new multi-year research and drug discovery collaboration and ...
read more
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ...
read more
Boehringer Ingelheim and Bridge Biotherapeutics announced they are entering into a new collaboration and license agreement with the goal of developing autotaxin inhibitor BBT-877.
read more
Boehringer Ingelheim announced today an agreement with Servier and its partner XOMA Corporation (Nasdaq: XOMA) to transfer XOMA’s technology and process for the commercial manufacture of gevokizumab, XOMA’s novel interleukin 1-beta (IL-1ß) allosteric...
read more
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center.
read more
Monday, February 03, 2020
Boehringer Ingelheim selected Docuvera to enable medical authors to build clinical and regulatory documents from pre-approved components of medical content.
read more
Wednesday, December 23, 2015
Boehringer Ingelheim will make a significant investment in biopharmaceutical production at its Vienna (Austria) site. There the research-driven pharmaceutical company will establish a new large-scale biopharmaceutical production facility for active ...
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more
Tuesday, November 11, 2014
Boehringer Ingelheim, one of the top 20 global pharma companies, has introduced IDBS’ [2]E-WorkBook Suite to eliminate data silos in the lab. The cross-domain platform has initially been deployed in North America with the next roll-out planned for ...
read more
Boehringer Ingelheim has signed with Zhangjiang Biotech & Pharmaceutical Base Development Company in Pudong, Shanghai a strategic alliance agreement and contract to build a cGMP biopharmaceuticals facility. The new site will provide full range of ...
read more
Wednesday, February 11, 2015
Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU ...
read more
Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity.
read more
Boehringer Ingelheim and Eli Lilly announced a research collaboration with DCRI for the prevention of Chronic heart failure and mortality after an acute Myocardial Infarction.
read more
Boehringer Ingelheim and Eli Lilly announced plans to expand their clinical trial program for empagliflozin in chronic heart failure with the EMPERIAL clinical trials.
read more
Thursday, November 16, 2017
Boehringer Ingelheim and MiNA have signed a collaboration and licensing agreement focused on the development of novel compounds to treat fibrotic liver diseases.
read more